Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2024-06-20

EMA Authorised: Atosiban SUN (atosiban (as acetate)) — Sun Pharmaceutical Industries Europe B.V.

View source ↗

Summary

The EMA authorised Atosiban SUN (atosiban) for use in managing preterm labor during pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atosiban SUN (atosiban)

Snippet

Status: Authorised. Therapeutic area: Obstetric Labor, Premature. MAH: Sun Pharmaceutical Industries Europe B.V.. Decision date: 21/03/2024